公司资料
Endonovo Therapeutics 股价、新闻与催化剂
- 股票代码:
- ENDV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States and traded publicly
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
As of Aug 17, 2026, ENDV was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
公司概览
业务概览
Endonovo Therapeutics was a medical technology company focused on bioelectronic or regenerative applications for inflammation and pain. Its story centered on device-based therapy rather than classic pharmaceuticals.
所在地与行业分类
Endonovo was headquartered in the United States and traded publicly. It sat in medical technology and bioelectronic medicine.
商业模式特征
The company depended on product development, commercialization, and the ability to show clinical utility. Investors historically watched device progress and strategic changes.
生物医药行业定位
Endonovo occupies a historical bioelectronic-device niche. It is outside biotech therapeutics and more closely aligned with device-driven care.
未来催化剂
- Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone. The market is focused on residual value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。